Similar articles

• Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder.

  Nelken RS, Ozel BZ, Leegant AR, Felix JC, Mishell DR Jr. Nelken RS, et al. Menopause. 2011 Sep;18(9):962-6. doi: 10.1097/gme.0b013e3182104977. Menopause. 2011. PMID: 21532512 Clinical Trial.
• A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women.

  Gittelman M, Weiss H, Seidman L. Gittelman M, et al. J Urol. 2014 Apr;191(4):1014-21. doi: 10.1016/j.juro.2013.11.019. Epub 2013 Nov 11. J Urol. 2014. PMID: 24231837 Clinical Trial.
• Better management of patients with overactive bladder with antimuscarinics?

  MacDiarmid S. MacDiarmid S. Int J Clin Pract. 2008 Jan;62(1):3-4. doi: 10.1111/j.1742-1241.2007.01627.x. Int J Clin Pract. 2008. PMID: 18173809 No abstract available.
• Oxybutynin in detrusor overactivity.

  Diokno A, Ingber M. Diokno A, et al. Urol Clin North Am. 2006 Nov;33(4):439-45, vii. doi: 10.1016/j.ucl.2006.06.003. Urol Clin North Am. 2006. PMID: 17011379 Review.
• Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.

  Chancellor MB, de Miguel F. Chancellor MB, et al. Geriatrics. 2007 May;62(5):15-24. Geriatrics. 2007. PMID: 17489643 Review.